Medicines and treatments

Clinical Effectiveness and Medicines Optimisation

The Clinical Effectiveness and Medicines Optimisation teams support the commissioning of medicines and other medical interventions which are effective when applied in appropriate populations of patients, which lead to improved outcomes for patients and which provide value for the use of resources.

We work with GPs and other stakeholders in the health and social care community, striving to ensure best use of medication and other treatments to secure the desired outcomes for patients and deliver value for money for the NHS.

Please click on the links below for further details of our areas of work:

Local decision making for specific medicines and treatments

Details of local commissioning policies for specific medicines and treatments are published on behalf of NEW Devon CCG and South Devon & Torbay CCG. These are categorised by body system.

Local decisions about specific medicines and treatments are made by the Clinical Policy Committee for NEW Devon CCG and South Devon & Torbay CCG, guided by the National Prescribing Centre principles and rationale for local decision making.

Clinical policy patient support information has been produced to provide clarity for patients, the public and staff about why and how a decision has been taken in respect of commissioning a particular treatment and what it will mean for patients.

Patient choice and the NHS Constitution

As part of the Devon Sustainability and Transformation Partnership (STP), the CCG is committed to enabling patient choice as set out in the NHS Constitution.

In England, under the NHS Constitution, patients ‘have the right to access consultant-led, non-emergency treatment within a maximum of 18 weeks, or for the NHS to take all reasonable steps to offer a range of alternative providers if this is not possible’.

Most patients also have the right to choose which hospital provider they are referred to.  

Exceptions include emergency and urgent services, cancer, maternity and mental health services. For example, if individuals need to be seen urgently by a specialist (such as for severe chest pain) they will be sent where they'll be seen most quickly. 

The CCG recognises that sometimes referrals are made outside the area that are not subject to patient choice.

To maximise convenience for patients and investment in local services, the CCG prefers and actively promotes local referrals wherever a clinically equivalent service exists, though patient choice will be respected.

Treatment in another European Economic Area country

Under the European Union Directive on patients’ rights in cross-border healthcare, patients are entitled to travel to a European Economic Area (EEA) country to purchase treatment.

If the treatment is medically necessary and the same as, or equivalent to, a service that they would be eligible to receive under the NHS, they can apply to their local CCG (NEW Devon CCG or South Devon and Torbay CCG) for prior approval. This is in order to ensure equity of treatment for all our residents. Reimbursement will not be authorised without prior approval.

The Directive covers UK patients choosing to be treated in another EEA country. This does not cover patients in England choosing to access treatment in Scotland, Wales or Northern Ireland.

Patients who wish to seek treatment in another EEA country should seek advice from their local CCG’s Individual Funding Panel:

Clinical guidance for prescribers

The local Joint Formularies promote safe, effective, and economic prescribing in both primary and secondary care. They provide clinical guidance on the management of a wide variety of conditions, which includes locally recommended drug choices. In compiling the formulary consideration is given to aspects of effectiveness, safety, appropriateness and cost effectiveness.

Shared care guidelines support the prescribing and monitoring of drug therapy where responsibilities for patient care are shared between specialists and the patients GP. 

Information for patients and healthcare professionals

Our information for Healthcare Professionals pages include information on managing medicines in care homes, medication review, medicines waste, locally produced summaries of the guidance published by the National Institute for Health and Care Excellence (NICE) and details of patient access scheme arrangements for individual drugs. 

Respiratory information for patients and healthcare professionals  includes resources such as interactive inhaler checklists, videos on correct inhaler use, information leaflets and inhaler device charts.

Prescribing guidance for gluten free products came into effect on 1 July 2017 following a local clinical review of NHS prescribing of gluten free foods in the North, East and West Devon area.

Infection control and tissue viability  guidance and information is available to help you provide clean, safe, quality care in your health or social care setting.

Rate this page